It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1982.
1982 | Mumbai, Maharashtra, India | ActiveBezel Pharma Pvt Ltd, a active private limited company, was established on 30 August 1982 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U45100MH1982PTC028103. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹2.00 M.
It upholds a compliant status. Its leadership includes Sachin Navinchandra Doshi (Director), Chetan Bhupatray Dani (Director). Past directors included Sachin Navinchandra Doshi, Priyushchnadra Ratilal Dhedhi, Chetan Navinchandra Doshi. It holds no open charges and ₹3.00 M settled loans. Its latest AGM occurred on 29 September 2024, with the balance sheet filed on 31 March 2024. It is based at 99 Kandivaligovt Industrial Estate Kandivali (W), Mumbai, Maharashtra, 400067.
U45100MH1982PTC028103
028103
30 August 1982
₹3.00 M
₹2.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Bezel Pharma Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sachin Navinchandra Doshi | Director | 01 Jul 2008 | Current |
| Chetan Bhupatray Dani | Director | 02 Sep 2002 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 15 Jul 2008 | Past |
| Pramod Abcsdd | Director | 14 Aug 2014 | Past |
| Pramod Abcsdd | Director | 14 Aug 2017 | Past |
| Pramod Abcsdd | Director | 15 Nov 2017 | Past |
| Pramod Abcsdd | Director | 16 May 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bezel Pharma Pvt Ltd, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 71.1% increase in profit. The company's net worth observed a substantial decline by a decrease of 177.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Bezel Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹3,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Sep 1984 | Canara Bank | ₹3.00 M | Satisfied |
Explore comprehensive loan charge details -
Bezel Pharma has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Bezel Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bezel Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Bezel Pharma Pvt Ltd last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Bezel Pharma Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
A charge registered on 22 Sep 1984 via Charge ID 90373212 with Canara Bank was fully satisfied on 19 Sep 2011. was recorded as a recent event.
Sachin Navinchandra Doshi was appointed as a Director was appointed as a Director on 01 Jul 2008 & has been associated with this company since 17 years 5 months . was recorded as a recent event.
Chetan Bhupatray Dani was appointed as a Director was appointed as a Director on 02 Sep 2002 & has been associated with this company since 23 years 2 months . was recorded as a recent event.
Progress on A charge with Canara Bank amounted to Rs. 3.00 M with Charge ID 90373212 was registered on 22 Sep 1984. was documented.
The CIN of Bezel Pharma Pvt Ltd is U45100MH1982PTC028103.
Bezel Pharma Pvt Ltd is headquartered at 99 Kandivaligovt Industrial Estate Kandivali (W), Mumbai, Maharashtra, 400067.
Bezel Pharma Pvt Ltd was incorporated on 30 August 1982.
The current directors of Bezel Pharma Pvt Ltd are
The primary industry of Bezel Pharma Pvt Ltd is Pharma.
Bezel Pharma Pvt Ltd is unlisted.
The authorized capital of Bezel Pharma Pvt Ltd is ₹3.00 M, and the paid-up capital is ₹2.00 M.
The compliance status of Bezel Pharma Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX